Sleep and hypertension

Chest

Volumn 138, Issue 2, 2010, Pages 434-443

  Calhoun, David A ^a   Harding, Susan M ^b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; HYPERTENSION; INSOMNIA; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; REVIEW; SLEEP; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION;

EID: 77955383051     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-2954     Document Type: Review

References (71)

1. Ohkubo T, Hozawa A, Nagai K, et al. Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population:the Ohasama study. J Hypertens. 2000;18(7):847-854.
2. Dolan E, Stanton AV, Thom S, et al;ASCOT Investigators. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients - an Anglo-Scandinavian cardiac outcomes trial substudy. J Hypertens. 2009;27(4):876-885.
3. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension. 2001;38(4):852-857.
4. Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. Predictors of all-cause mortality in clinical ambulatory monitoring:unique aspects of blood pressure during sleep. Hypertension. 2007;49(6):1235-1241.
5. Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005;46(1):156-161.
6. Pedersen OL, Mancia G, Pickering T, et al;VALUE Trial Group. Ambulatory blood pressure monitoring after 1 year on valsartan or amlodipine-perindopril treatment:a VALUE substudy. J Hypertens. 2007;25(3):707-712. (Pubitemid 46213810)
7. Salles GF, Cardoso CRL, Muxfeldt ES. Prognostic infl uence of offi ce and ambulatory blood pressures in resistant hypertension . Arch Intern Med. 2008;168(21):2340-2346.
8. Cook NR, Cohen J, Hebert PR, Taylor JO, Hennekens CH. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med. 1995;155(7): 701-709.
9. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease:metaanalysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009; 338(191):1245-1253.
10. National Center for Health Statistics. QuickStats:Percen tage of adults who reported an average of 6 hours of sleep per 24-hour period, by sex and age group-United States, 1985 and 2004. MMWR Morb Mortal Wkly Rep. 2005;54(37):933.
11. Gottlieb DJ, Redline S, Nieto FJ, et al. Association of usual sleep duration with hypertension:the Sleep Heart Health Study. Sleep. 2006;29(8):1009-1014.
12. Cappuccio FP, Stranges S, Kandala NB, et al. Genderspecific associations of short sleep duration with prevalent and incident hypertension:the Whitehall II Study. Hypertension. 2007;50(4):693-700. [Erratum:Hypertension 2007;50(5):e170].
13. Gangwisch JE, Heymsfi eld SB, Boden-Albala B, et al. Short sleep duration as a risk factor for hypertension:analyses of the fi rst National Health and Nutrition Examination Survey. Hypertension. 2006;47(5):833-839.
14. van den Berg JF, Tulen JHM, Neven AK, et al. Sleep duration and hypertension are not associated in the elderly. Hypertension. 2007;50(3):585-589.
15. Lopez-Garcia E, Faubel R, Guallar-Castillon P, Leon-Muñoz L, Banegas JR, Rodriguez-Artalejo F. Self-reported sleep duration and hypertension in older Spanish adults. J Am Geriatr Soc. 2009;57(4):663-668.
16. Knutson KL, Van Cauter E, Rathouz PJ, et al. Association between sleep and blood pressure in midlife:the CARDIA sleep study. Arch Intern Med. 2009;169(11):1055-1061.
17. Javaheri S, Storfer-Isser A, Rosen CL, Redline S. Sleep quality and elevated blood pressure in adolescents. Circulation. 2008;118(10):1034-1040.
18. Friedman O, Shukla Y, Logan AG. Relationship between self-reported sleep duration and changes in circadian blood pressure. Am J Hypertens. 2009;22(11):1205-1211.
19. Bonnet MH. Evidence for the pathophysiology of insomnia. Sleep. 2009;32(4):441-442.
20. Phillips B, Mannino DM. Do insomnia complaints cause hypertension or cardiovascular disease? J Clin Sleep Med. 2007;3(5):489-494.
21. Phillips B, Bůzková P, Enright P; Cardiovascular Health Study Research Group. Insomnia did not predict incident hypertension in older adults in the cardiovascular health study. Sleep. 2009;32(1):65-72.
22. Lanfranchi PA, Pennestri MH, Fradette L, et al. Nighttime blood pressure in normotensive subjects with chronic insomnia: implication for cardiovascular risk. Sleep. 2009;32(6):760-766.
23. Vgontzas AN, Liao D, Bixler EO, Chrousos GP, Vela-Bueno A. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep. 2009;32(4):491-497.
24. Walters AS, Rye DB. Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep. 2009;32(5):589-597.
25. Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population . J Psychosom Res. 2002;53(1):547-554.
26. Phillips B, Hening W, Britz P, Mannino D. Prevalence and correlates of restless legs syndrome:results from the 2005 National Sleep Foundation Poll. Chest. 2006;129(1):76-80.
27. Ulfberg J, Nyström B, Carter N, Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years:an association with somatic disease and neuropsychiatric symptoms. Mov Disord. 2001;16(6):1159-1163. (Pubitemid 36041234)
28. Winkelman JW, Shahar E, Sharief I, Gottlieb DJ. Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology. 2008;70(1):35-42.
29. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology. 2000;54(5):1064-1068.
30. Högl B, Kiechl S, Willeit J, et al. Restless legs syndrome:a community-based study of prevalence, severity, and risk factors . Neurology. 2005;64(11):1920-1924.
31. Winkelman JW, Finn L, Young T. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med. 2006;7(7):545-552.
32. Pennestri MH, Montplaisir J, Colombo R, Lavigne G, Lanfranchi PA. Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology. 2007;68(15): 1213-1218.
33. Siddiqui F, Strus J, Ming X, Lee IA, Chokroverty S, Walters AS. Rise of blood pressure with periodic limb movements in sleep and wakefulness. Clin Neurophysiol. 2007;118(9): 1923-1930. (Pubitemid 47187754)
34. Billars L, Hicks A, Bliwise D, et al. Hypertension risk and PLMS in restless legs syndrome [abstract]. Sleep. 2007; 30(suppl):A297-A298.
35. Fletcher ED, DeBehnke RD, Lovoi MS, et al. Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med. 1985;103(2):190-195.
36. Lavie P, Ben-Yosef R, Rubin AE. Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J. 1984;108(2):373-376.
37. Worsnop CJ, Naughton MT, Barter CE, Morgan TO, Anderson AI, Pierce RJ. The prevalence of obstructive sleep apnea in hypertensives. Am J Respir Crit Care Med. 1998; 157(1):111-115.
38. Durán-Cantolla J, Aizpuru F, Martínez-Null C, Barbé-Illa F. Obstructive sleep apnea/hypopnea and systemic hypertension . Sleep Med Rev. 2009;13(5):323-331.
39. Grunstein R, Wilcox I, Yang TS, Gould Y, Hedner J. Snoring and sleep apnoea in men:association with central obesity and hypertension. Int J Obes Relat Metab Disord. 1994;17(9): 533-540. (Pubitemid 23269132)
40. Grunstein RR, Stenlöf K, Hedner J, Sjöström L. Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects(SOS) Study. Int J Obes Relat Metab Disord. 1995;19(6):410-418.
41. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension:population study. BMJ. 2000;320(7233):479-482.
42. Young T, Peppard P, Palta M, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med. 1997;157(15):1746-1752. (Pubitemid 27327411)
43. Hla KM, Young TB, Bidwell T, Palta M, Skatrud JB, Dempsey J. Sleep apnea and hypertension. A population-based study. Ann Intern Med. 1994;120(5):382-388.
44. Bixler EO, Vgontzas AN, Lin HM, et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med. 2000;160(15):2289-2295.
45. Durán J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med. 2001;163(3 pt 1):685-689.
46. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. J Am Med Assoc. 2000;283(14):1829-1836.
47. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342(19):1378-1384. (Pubitemid 30262394)
48. Peppard PE, Young T. Sleep-disordered breathing and hypertension [Reply]. N Engl J Med. 2000;343(13):967.
49. O'Connor GT, Caffo B, Newman AB, et al. Prospective study of the association between sleep-disordered breathing and hypertension:the Sleep Heart Health Study. Am J Respir Crit Care Med. 2009;179(12):1159-1164.
50. Peppard PE. Is obstructive sleep apnea a risk factor for hypertension? - differences between the Wisconsin Sleep Cohort and the Sleep Heart Health Study. J Clin Sleep Med. 2009;5(5):404-405.
51. Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007;50(2):417-423.
52. Alajmi M, Mulgrew AT, Fox J, et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea:a meta-analysis of randomized controlled trials. Lung. 2007;185(2):67-72.
53. Mo L, He QY. Effect of long-term continuous positive airway pressure ventilation on blood pressure in patients with obstructive sleep apnea hypopnea syndrome:a meta-analysis of clinical trials [in Chinese]. Zhonghua Yi Xue Za Zhi. 2007;87(17):1177-1180.
54. Haentjens P, Van Meerhaeghe A, Moscariello A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome:evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med. 2007;167(8):757-764. (Pubitemid 46658332)
55. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96(4):1897-1904.
56. Narkiewicz K, Kato M, Phillips BG, Pesek CA, Davison DE, Somers VK. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffi c in obstructive sleep apnea. Circulation. 1999;100(23):2332-2335.
57. Ishida K, Kato M, Kato Y, et al. Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea. Chest. 2009; 136(1):125-129.
58. de Lima AM, Franco CM, de Castrol CM, Bezerra AD, Ataíde L Jr, Halpern A. Effects of nasal continuous positive airway pressure treatment on oxidative stress and adiponectin levels in obese patients with obstructive sleep apnea. Respiration. 2010;79(5):370-376.
59. Phillips CL, Yang Q, Williams A, et al. The effect of short-term withdrawal from continuous positive airway pressure therapy on sympathetic activity and markers of vascular infl ammation in subjects with obstructive sleep apnoea. J Sleep Res. 2007;16(2):217-225.
60. Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med. 2007;176(7):706-712. (Pubitemid 351204501)
61. Kitahara Y, Hattori N, Yokoyama A, Nakajima M, Kohno N. Effect of CPAP on brachial-ankle pulse wave velocity in patients with OSAHS:an open-labelled study. Respir Med. 2006;100(12):2160-2169. (Pubitemid 44718394)
62. Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens. 2001;19(12):2271- 2277.
63. Calhoun DA, Nishizaka MK, Zaman MA, Harding SM. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest. 2004;125(1): 112-117.
64. Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL, Cofi eld SS, Harding SM, Calhoun DA. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest. 2007;131(2):453-459.
65. Grote L, Hedner J, Peter JH. Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension. J Hypertens. 2000;18(6):679-685.
66. Lavie P, Hoffstein V. Sleep apnea syndrome:a possible contributing factor to resistant. Sleep. 2001;24(6):721-725. (Pubitemid 32823738)
67. Elias RM, Castro MCM, de Queiroz EL, Abensur H, Romão JE Jr, Lorenzi-Filho G. Obstructive sleep apnea in patients on conventional and short daily hemodialysis. Am J Nephrol. 2009;29(6):493-500.
68. Logan AG, Tkacova R, Perlikowski SM, et al. Refractory hypertension and sleep apnoea:effect of CPAP on blood pressure and barorefl ex. Eur Respir J. 2003;21(2):241-247.
69. Chiu KL, Ryan CM, Shiota S, et al. Fluid shift by lower body airway cross-sectional increases pharyngeal resistance in healthy subjects. Am J Respir Crit Care Med. 2006;174(12): 1378-1383.
70. Bucca CB, Brussino L, Battisti A, et al. Diuretics in obstructive sleep apnea with diastolic heart failure. Chest. 2007; 132(2):440-446.
71. Gaddam K, Pimenta E, Thomas SJ, et al. Spironolactone reduces severity of obstructive sleep apnea in patients with resistant hypertension:a preliminary report. J Hum Hypertens. 2009;doi:10.1038/jhh.2009.96 [Epub ahead of print].